Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(57%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
29%
Ph not_applicable
3
43%
Ph phase_2
2
29%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(1)
Other(2)

Detailed Status

Recruiting4
unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (28.6%)
Phase 22 (28.6%)
N/A3 (42.9%)

Trials by Status

recruiting457%
unknown229%
completed114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
RADIATION
Total Trials
7